How do Cincinnati Financial and Zimmer Biomet compare by revenue?

Cincinnati Financial reported revenue of $2.8B in Q1 FY2026, while Zimmer Biomet reported $2.1B in Q1 FY2026. Cincinnati Financial is 1.3× larger by last-quarter revenue.

Which is growing revenue faster, Cincinnati Financial or Zimmer Biomet?

Cincinnati Financial's latest revenue grew -1.7% year-over-year, versus 9.3% for Zimmer Biomet. Zimmer Biomet is growing faster on a YoY basis.

Which has a higher net margin, Cincinnati Financial or Zimmer Biomet?

Cincinnati Financial's net margin is 9.6% vs Zimmer Biomet's 11.4%. Zimmer Biomet has the higher bottom-line margin.

What is the 2-year revenue CAGR for Cincinnati Financial vs Zimmer Biomet?

Over the trailing 8 quarters, Cincinnati Financial compounded revenue at roughly 5.2% per year, versus 3.7% for Zimmer Biomet. Cincinnati Financial has the faster medium-term growth trajectory.

Where does this CINF vs ZBH data come from?

All figures are parsed directly from SEC EDGAR 10-Q / 10-K / 20-F / 6-K filings (for US-listed issuers) or EDINET filings (for Japanese issuers), then normalised into a common schema. Numbers update automatically as new filings are released.

vs

Side-by-side financial comparison of Cincinnati Financial (CINF) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Cincinnati Financial is the larger business by last-quarter revenue ($2.8B vs $2.1B, roughly 1.3× Zimmer Biomet). Zimmer Biomet runs the higher net margin — 11.4% vs 9.6%, a 1.8% gap on every dollar of revenue. On growth, Zimmer Biomet posted the faster year-over-year revenue change (9.3% vs -1.7%). Over the past eight quarters, Cincinnati Financial's revenue compounded faster (5.2% CAGR vs 3.7%).

Cincinnati FinancialCINFEarnings & Financial Report

Nasdaq · Financials · Fire, Marine & Casualty Insurance

Cincinnati Financial Corporation offers property and casualty insurance, its main business, through The Cincinnati Insurance Company, The Cincinnati Indemnity Company and The Cincinnati Casualty Company. The company has 1.01% of the domestic property and casualty insurance premiums, which ranks it as the 20th largest insurance company by market share in the U.S.

Zimmer BiometZBHEarnings & Financial Report

NYSE · Health Care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

CINF vs ZBH — Head-to-Head

Bigger by revenue

CINF

1.3× larger

$2.8B

$2.1B

Growing faster (revenue YoY)

ZBH

+11.0% gap

9.3%

-1.7%

Higher net margin

ZBH

1.8% more per $

11.4%

9.6%

Faster 2-yr revenue CAGR

CINF

Annualised

5.2%

3.7%

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric	CINF	ZBH
Revenue	$2.8B	$2.1B
Net Profit	$274.0M	$238.3M
Gross Margin	—	64.6%
Operating Margin	—	17.9%
Net Margin	9.6%	11.4%
Revenue YoY	-1.7%	9.3%
Net Profit YoY	404.4%	30.5%
EPS (diluted)	—	$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue

CINF

ZBH

Q1 26	$2.8B	$2.1B
Q4 25	$3.1B	$2.2B
Q3 25	$3.7B	$2.0B
Q2 25	$3.2B	$2.1B
Q1 25	$2.6B	$1.9B
Q4 24	$2.5B	$2.0B
Q3 24	$3.3B	$1.8B
Q2 24	$2.5B	$1.9B

Net Profit

CINF

ZBH

Q1 26	$274.0M	$238.3M
Q4 25	$676.0M	$139.4M
Q3 25	$1.1B	$230.9M
Q2 25	$685.0M	$152.8M
Q1 25	$-90.0M	$182.0M
Q4 24	$405.0M	$239.5M
Q3 24	$820.0M	$249.1M
Q2 24	$312.0M	$242.8M

Gross Margin

CINF

ZBH

Q1 26	—	64.6%
Q4 25	—	64.7%
Q3 25	—	72.1%
Q2 25	—	71.5%
Q1 25	—	71.2%
Q4 24	—	71.0%
Q3 24	—	70.5%
Q2 24	—	71.5%

Operating Margin

CINF

ZBH

Q1 26	—	17.9%
Q4 25	27.2%	6.9%
Q3 25	37.9%	17.6%
Q2 25	26.3%	14.4%
Q1 25	-5.0%	15.3%
Q4 24	18.9%	19.2%
Q3 24	31.3%	15.3%
Q2 24	15.2%	18.1%

Net Margin

CINF

ZBH

Q1 26	9.6%	11.4%
Q4 25	21.9%	6.2%
Q3 25	30.1%	11.5%
Q2 25	21.1%	7.4%
Q1 25	-3.5%	9.5%
Q4 24	16.0%	11.8%
Q3 24	24.7%	13.7%
Q2 24	12.3%	12.5%

EPS (diluted)

CINF

ZBH

Q1 26	—	$1.22
Q4 25	$4.29	$0.71
Q3 25	$7.11	$1.16
Q2 25	$4.34	$0.77
Q1 25	$-0.57	$0.91
Q4 24	$2.57	$1.18
Q3 24	$5.20	$1.23
Q2 24	$1.98	$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric	CINF	ZBH
Cash + ST InvestmentsLiquidity on hand	$1.2B	$424.2M
Total DebtLower is stronger	$816.0M	$7.5B
Stockholders' EquityBook value	$15.7B	$12.7B
Total Assets	$41.2B	$22.7B
Debt / EquityLower = less leverage	0.05×	0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments

CINF

ZBH

Q1 26	$1.2B	$424.2M
Q4 25	$148.0M	$591.9M
Q3 25	$1.6B	$1.3B
Q2 25	$1.1B	$556.9M
Q1 25	$1.1B	$1.4B
Q4 24	$1.3B	$525.5M
Q3 24	$1.8B	$569.0M
Q2 24	$771.0M	$420.1M

Total Debt

CINF

ZBH

Q1 26	$816.0M	$7.5B
Q4 25	$861.0M	—
Q3 25	$858.0M	—
Q2 25	$859.0M	—
Q1 25	$853.0M	—
Q4 24	$850.0M	—
Q3 24	$849.0M	—
Q2 24	$849.0M	—

Stockholders' Equity

CINF

ZBH

Q1 26	$15.7B	$12.7B
Q4 25	$15.9B	$12.7B
Q3 25	$15.4B	$12.8B
Q2 25	$14.3B	$12.5B
Q1 25	$13.7B	$12.4B
Q4 24	$13.9B	$12.5B
Q3 24	$13.8B	$12.4B
Q2 24	$12.8B	$12.7B

Total Assets

CINF

ZBH

Q1 26	$41.2B	$22.7B
Q4 25	$41.0B	$23.1B
Q3 25	$40.6B	$23.5B
Q2 25	$38.8B	$22.9B
Q1 25	$37.3B	$22.2B
Q4 24	$36.5B	$21.4B
Q3 24	$37.0B	$21.7B
Q2 24	$34.8B	$21.5B

Debt / Equity

CINF

ZBH

Q1 26	0.05×	0.59×
Q4 25	0.05×	—
Q3 25	0.06×	—
Q2 25	0.06×	—
Q1 25	0.06×	—
Q4 24	0.06×	—
Q3 24	0.06×	—
Q2 24	0.07×	—

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric	CINF	ZBH
Operating Cash FlowLast quarter	—	$359.4M
Free Cash FlowOCF − Capex	—	$245.9M
FCF MarginFCF / Revenue	—	11.8%
Capex IntensityCapex / Revenue	—	—
Cash ConversionOCF / Net Profit	—	1.51×
TTM Free Cash FlowTrailing 4 quarters	—	$1.4B